Axon enterprises stock

Axon enterprises stock DEFAULT

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock quotes are delayed as per exchange requirements. Fundamental company data and analyst estimates provided by FactSet. Copyright 2019© FactSet Research Systems Inc. All rights reserved. Source: FactSet

Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. Source: FactSet

Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Sources: FactSet, Dow Jones

Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones

ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. Sources: FactSet, Dow Jones

Bonds: Bond quotes are updated in real-time. Sources: FactSet, Tullett Prebon

Currencies: Currency quotes are updated in real-time. Sources: FactSet, Tullett Prebon

Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Source: FactSet

Data are provided 'as is' for informational purposes only and are not intended for trading purposes. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Data may be intentionally delayed pursuant to supplier requirements.

Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright 2019© Refinitiv. All rights reserved. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Cryptocurrencies: Cryptocurrency quotes are updated in real-time. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies)

Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Source: Kantar Media

Sours: https://www.wsj.com/market-data/quotes/AXON

Axon Enterprise Inc AXON:NASDAQ

KEY STATS

  • Open178.52
  • Day High180.61
  • Day Low177.70
  • Prev Close176.62
  • 52 Week High212.37
  • 52 Week High Date02/11/21
  • 52 Week Low96.66
  • 52 Week Low Date11/02/20
  • Market Cap11.759B
  • Shares Out65.68M
  • 10 Day Average Volume0.27M
  • Dividend-
  • Dividend Yield-
  • Beta0.41
  • YTD % Change46.11

RATIOS/PROFITABILITY

  • EPS (TTM)-1.08
  • P/E (TTM)-165.89
  • Fwd P/E (NTM)123.72
  • EBITDA (TTM)-128.275M
  • ROE (TTM)-7.12%
  • Revenue (TTM)806.40M
  • Gross Margin (TTM)62.11%
  • Net Margin (TTM)-8.69%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

There is no recent news for this security.

There is no recent news for this security.

Sours: https://www.cnbc.com/quotes/AXON
  1. Cod mw mp5
  2. Ac can adapter
  3. Colon cleanse essential oils

Down 25%, Is Now the Time to Buy Axon Enterprise Stock?

Axon Enterprise(NASDAQ:AXON) is trying to become the world's best hardware and software provider for law enforcement agencies. From its flagship TASER product to workflow software backed up on Evidence.com, the company offers numerous products to police departments around the globe. Even though Axon has grown its business substantially over the last few years, and while putting up another solid earnings result in the first quarter, the stock price is down over 25% in the last three months.

Is now the time to buy some shares in Axon, with the stock trading at a discount? Let's take a look. 

Q1 results filled with growing metrics

In the first quarter of 2021, Axon's revenue was up 33% from 2020 to $195 million. All three of Axon's operating segments (TASER, Sensors, and Cloud) grew at a rapid pace. TASER sales were up 30% year over year to $100 million, while Sensor sales grew 36% to $44 million and Cloud revenue grew 34% to $52 million.

A female police officer holds a TASER weapon as if preparing to shoot it with a police vehicle in the background

Image source: Axon Enterprise.

While the top-line numbers looked great, consolidated gross margin hit 63.6% in Q1, the highest that number's been in 10 quarters. This shows that Axon is starting to see some leverage with the unit economics of its business. The company is not currently GAAP profitable (although it has been in prior quarters), so gross margin is the best way to evaluate its financial health at the moment. Investors should watch and expect that in the future the company will start generating consistent GAAP profits and cash flow.

Management also updated investors with 2021 and 2022 guidance in the Q1 report. Axon now expects around $800 million in revenue this year and $920 million next year. Since customers (i.e., law enforcement departments) sign five- or even 10-year deals with Axon, its future revenue is highly predictable.

Potential for growth abounds

Axon continues to add new hardware and software products to its portfolio suite that it bundles and sells to law enforcement agencies. Q1 was no exception. New product bookings were up 130% in Q1, handily outpacing the growth of Axon's legacy solutions.

One of these new products is Axon Performance, which helps police departments review body camera footage more efficiently and makes sure officers are following appropriate department guidelines. Axon Performance works well with Axon's latest body camera product, the Axon Body 3, and is an example of how the company is integrating its hardware and software product suite, making it an easier pitch when it sells to police departments. Axon Performance also locks in departments to Evidence.com, Axon's cloud-based evidence management system. 

On other fronts, Axon just announced a new officer virtual reality (VR) training program. The solution, in partnership with Taiwan-based HTC (which provides the VR headset), helps officers train in lifelike situations before heading out into the real-world conflicts they are eventually going to meet. This VR program is not only something Axon can add to its product bundle, but also works to integrate its TASER and body cameras into police officer training, further ingraining the hardware tools within the department.

These two new products are just the tip of the iceberg. Axon continually comes out with new solutions for its customer base, which has led its contracted backlog to reach $1.79 billion at the end of Q1, up from $1.27 billion a year ago, as more and more police departments, federal agencies, and correctional facilities sign multi-year contracts for Axon's solutions.

But is the stock a buy?

At a market cap of $8.45 billion, Axon is trading at a forward price-to-sales ratio (P/S) of 10.5 based on the midpoint of its 2021 sales guidance. This is expensive even when considering the high gross margins of Axon's business. However, if you look at the $1.79 billion backlog and the opportunities that abound expanding its hardware and software bundle across the globe, there is a compelling case that Axon can grow its revenue at a 20%-plus rate over the next five years and beyond. If you believe that is the case, and are bullish on Axon's business prospects, it is entirely reasonable to buy shares at a P/S above 10 if you plan on holding for the long term. 

Sours: https://www.fool.com/investing/2021/05/25/down-25-is-now-time-to-buy-axon-enterprise-stock/

I looked at it. She let her hair loose in one motion and said - let's go to the blood cucumber, my beloved I took her in my arms, so that one hand. Lay under her beetle, and the second under the foot, and carried it to the bedroom I didnt even put it on, but threw it on the bed and pounced on the top. I spread her legs wider, I settled down in my legs and started fondling my little girl, my little bitch, which so wanted to make this night I took off nee.

Tufelki and nachal pokryvat potseluyami ee nozhki in chulkah, osobenno ostanavlivayas nA kolenkah - ochen they are normally menya vozbuzhdali, Nr potom I moved dalshe and nakonets upersya in ee chernye panties.

Stock axon enterprises

Squatting and crushing her mistress's breasts with both hands, I hope you enjoyed it. Because to me - very much. You excite me like no one else, my girl. - said the stranger, her voice could be heard that she was smiling. Yes, very much.

Invest In The Future of Policing! $AXON Stock Analysis.

That Ive already gone into a rage. suddenly pulled my head by the hair and holding it for a little while, without looking at my face, she said: Ill do something now, dont be. Surprised, okay. With these words, she raised herself even more, so that her swollen lips were centimeters in thirty from my face.

You will also like:

It was completely different. This was done by other people in other places as well. Natasha was kicked out of the institute in no time.



3684 3685 3686 3687 3688